“In addition, PLife REIT owns three private hospitals in Singapore, which have captured the majority of the market share,” they note in their Feb 20 report.
DBS Group Research analysts Rachel Tan and Derek Tan have maintained their “buy” call on Parkway Life REIT (PLife REIT) (SGX:C2PU
) , favouring the trust for its strong earnings visibility amid the current backdrop of a volatile and uncertain market outlook.
“PLife REIT is one of Asia’s largest listed healthcare REITs by asset size and a rare jewel amongst Singapore REITs (S-REITs) that offers highly visible, stable and sustainable earnings by virtue of its resilient industry and long leases with downside risk protection.
